COA5 has an essential role in the early stage of mitochondrial complex IV assembly
Jia Xin Tang,Alfredo Cabrera-Orefice,Jana Meisterknecht,Lucie Taylor,Geoffray Monteuuis,Maria Ekman Stensland,Adam Szczepanek,Karen L Stals,James Davison,Langping He,Sila Hopton,Tuula A Nyman,Christopher B Jackson,Angela Pyle,Monika Winter,Ilka Wittig,Robert W Taylor
DOI: https://doi.org/10.1101/2024.08.27.24312374
2024-08-28
Abstract:Pathogenic variants in cytochrome c oxidase assembly factor 5 (COA5), a proposed complex IV (CIV) assembly factor, have been shown to cause clinical mitochondrial disease with two siblings affected by neonatal hypertrophic cardiomyopathy manifesting a rare, homozygous COA5 missense variant (NM_001008215.3: c.157G>C, p.Ala53Pro). The most striking observation in the affected individuals was an isolated impairment in the early stage of mitochondrial CIV assembly. In this study, we report an unrelated family in who we have identified the same COA5 variant with patient-derived fibroblasts and skeletal muscle biopsies replicating an isolated CIV deficiency. A CRISPR/Cas9-edited homozygous COA5 knockout U2OS cell line with similar biochemical profile was generated to interrogate the functional role of the human COA5 protein. Mitochondrial complexome profiling pinpointed a role for COA5 in early CIV assembly, more specifically, its involvement in the stage between MTCO1 maturation and the incorporation of MTCO2. We therefore propose that the COA5 protein plays an essential role for the biogenesis of MTCO2 and its integration into the early CIV assembly intermediate for downstream assembly of the functional holocomplex.